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Abstract
Objectives: To provide an analytical overview of contemporary indications, techniques, and outcomes of
urologic minilaparoscopy (ML) in multiple European centers.
Methods: Data of patients who had undergone a minilaparoscopic urologic procedure at nine European insti-
tutions between 2009 and 2012 were retrospectively gathered. Surgical procedures were classified as upper or
lower urinary tract and as ablative or extirpative and reconstructive. The main surgical outcome parameters
were analyzed and relevant operative data related to the surgical technique were recorded.
Results: Overall, 192 patients (mean age 45.25– 17.8 years) were included in the analysis. Most of them were
nonobese (mean body mass index [BMI] 24.7– 3.6 kg/m2) at low estimated surgical risk (mean American Society
of Anesthesiologists [ASA] 1.69– 0.68). Indications for surgery were mostly nononcologic (132 cases, 68.8%).
Most of the procedures were done in the upper urinary tract (133 cases, 69.2%) and were mostly with a
reconstructive intent (109 cases, 56.7%). Overall operative time was 132.7– 52.3 minutes with an estimated blood
loss of 60.9– 47.6mL while the mean hospital stay was 5– 2.1 days. Most of the postoperative complications
were low Clavien grade (1 and 2), with only one (0.5%) grade 3 and one (0.5%) grade 4 complications recorded.
Conclusions: A broad range of common procedures can be safely and effectively performed with ML tech-
niques. By duplicating the principles of standard laparoscopy, but potentially offering less surgical scar and
trauma, ML can be regarded as a viable option when looking for a virtually ‘‘scarless’’ surgery.
Introduction
The idea of performing surgical procedures with no scarhas gained attention in the urological community over the
last 5 years. Based on this concept, novel surgical approaches,
such as natural orifice translumenal endoscopic surgery
(NOTES) and laparoendoscopic single-site surgery (LESS),
have been explored with the ultimate aim of minimizing the
surgical morbidity and fostering patient recovery.1
At this time, only hybrid NOTES or NOTES-assisted
laparoscopic techniques seem to be ready for immediate
implementation in clinical practice.2,3 LESS has been in-
creasingly adopted worldwide, in urology and in other
surgical specialties.4,5 Nevertheless, the claimed advan-
tages of LESS over the traditional laparoscopic approach
remain to be fully demonstrated and its disadvantages are
widely recognized.1 Moreover, although feasible, pure
LESS remains a technical challenge for the surgeon, so
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that a mix of techniques could be the key for its im-
plementation.6
Recently, minilaparoscopy (ML) has been rediscovered in
an attempt to reduce the trauma on the abdominal wall de-
rived from standard laparoscopic access, improving cosmetic
outcome and recovery.7 This rediscovery has been fuelled by
the availability of more reliable instrumentation and by the
fact that ML allows minimal abdominal scar, meanwhile
preserving the key principle of triangulation.
Over the last few years, many minilaparoscopic proce-
dures have been successfully performed in several surgical
disciplines.8,9 In urology, evidence supporting ML has been
limited to small case series or case–control studies from se-
lected centers with laparoscopic expertize.10–12 Thus, more
robust analyses of larger samples are desirable to corroborate
positive findings from early series.
This study was initiated as a collaborative effort among
institutions pioneering the development of urologic ML, with
the purpose of providing an analytical overview of indica-
tions, techniques, and outcomes of this technique in con-
temporary practice.
Patients and Methods
Study design
Data of patients who had undergone a minilaparoscopic
urologic procedure at nine European institutions between 2009
and 2012 were retrospectively collected and gathered into a
standardized datasheet. All patients had consented specifically
and each group had performed the procedures according to its
own protocols, inclusion criteria, and techniques.
Outcome analysis
Demographic data included age, gender, body mass index
(BMI), past history of previous abdominal/pelvic surgery, the
American Society of Anesthesiologists (ASA) score, and
indications for ML.
Surgical procedures were classified as upper or lower
urinary tract and as ablative or extirpative and reconstructive.
The main surgical outcome parameters were analyzed, in-
cluding operative time, estimated blood loss, perioperative
complications, transfusions, length of hospital stay, and vi-
sual analog pain score (VAS)AU5c . Intraoperative complications
were classified according to a modified Satava system,13
whereas postoperative complications were graded according
to Clavien-Dindo.14
Relevant operative data related to the surgical technique
were recorded, including the number and size of the trocars as
well as the approach (transperitoneal or retroperitoneal).
All patient data were collected in an excel spreadsheet
(Microsoft Corp., Redmond, WA). Data of continuous vari-
ables are expressed as mean – standard deviation. Binary and
categorical variables are reported as counts and percentages.
Results
Demographics
Overall, 192 patients (mean age 45.25– 17.8 years) were
included in the analysis (T1c Table 1). Most of them were non-
obese (mean BMI 24.7 – 3.6 kg/m2) at low estimated surgical
risk (mean ASA 1.69 – 0.68). Indications for surgery were
mostly nononcologic (132 cases, 68.8%). Most of the pro-
cedures were done in the upper urinary tract (133 cases,
69.2%) and were mostly with a reconstructive intent (109
cases, 56.7%).
Instruments and surgical techniques
In all cases the 3-mm minilaparoscopic set from Karl
Storz (Tuttlingen, Germany) was used. A full range of in-
struments are available, including graspers, dissectors, scis-
sors, suction-irrigation cannulas, and needle holders. This is a
completely reusable set with 36-cm-long instruments, as well
as shorter (20 and 30 cm long) 3- and 2-mm instruments. The
trocars are rigid cannulas with a metal conical-tipped trocar
and silicone leaflet valves to help in maintaining pneumo-
peritoneum ( b F1Fig. 1). A variety of port configurations and
combinations were adopted depending on the procedure.
For radical prostatectomy, the patient was placed in the
Trendelenburg supine position ( b F2Fig. 2a). A 15-mm skin in-
cision was made laterally to the umbilical scar to create
a preperitoneal space by introducing a dissecting balloon
trocar. After that, the balloon trocar was replaced by a 12-mm
optical trocar. Two 3.5-mm trocars were positioned medially
to the anterior superior iliac spine, bilaterally. One 5-mm
trocar was placed *3 fingerbreadths medially to the left
anterior superior iliac spine, whereas another 3.5-mm trocar
in the right pararectal line between the optical trocar and the
previously placed right 3.5-mm trocar.
For the pyeloplasty, both the transperitoneal (72 cases,
68.3%) and retroperitoneal approaches (34 cases, 31.7%)
were used. The Anderson-Hynes technique was mostly
adopted (85 cases, 79.5%), whereas Foley Y-V (20 cases,
18.7%) or Fenger (2 cases, 1.8%) techniques were selectively
used. For the transperitoneal approach (Fig. 2b), the first 3.5-
mm camera port was placed 2 cm laterally to the umbilicus,
on the basis of patient body habitus. Then, under direct vi-
sion, other two 3.5-mm trocars were placed along the mid-
clavicular line, right or left depending on the side of the
procedure. A fourth 3.5-mm trocar, placed just below the
xiphoid, was used as a liver retractor in case of right-sided
procedures.10 For the retroperitoneal approach (Fig. 2c), a
retroperitoneal tunnel was created through a 6mm skin in-
cision below the inferior edge of the 12th rib. To develop the
retroperitoneal space, a 6-mm homemade dissecting balloon
trocar was used. Then, two 3.5-mm working trocars were
placed under endoscopic control to achieve triangulation.11
For the nephrectomy, a transperitoneal approach was
chosen for all the cases (Fig. 2d). A 5-mm optical trocar was
introduced under direct vision through the umbilicus.12 Three
to four 3.5-mm trocars were then introduced under direct
vision along the left pararectal line in a linear fashion. The
camera port was switched to a 3-mm laparoscope and intro-
duced through the most cephalic 3.5-mm trocar. Finally, the
fourth 3-mm trocar was normally placed at the ancillary line
at the tip of the 12th rib to optimize retraction.
For the adrenalectomy, a lateral retroperitoneal ap-
proach was adopted in all the cases. Immediately below the
12th rib, a dissecting balloon trocar was inserted at the
level of the inferior lumbar (Petit) triangle to develop a
retroperitoneal space. After removal of the balloon trocar,
a 3.5-mm optical trocar was inserted and fixed with a silk
suture. Under laparoscopic control, remaining ports were
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introduced, including two 3.5-mm trocars inserted below
(along the lateral border of the sacrospinalis muscle) and
anteriorly (along the anterior axillary line) to the 12th rib,
respectively, so that the three ports formed a line corre-
sponding to a subcostal incision.
Surgical outcomes
The overall operative time was 132.7– 52.3 minutes with
an estimated blood loss of 60.9 – 47.6mL while the mean
hospital stay was 5 – 2.1 days. InT2c Table 2 the specific out-
comes for the most commonly performed procedures are
detailed.
A limited number of perioperative adverse events were
observed in the present series. Only Satava grade 1 intra-
operative complications were recorded (8.3% of all the
cases). These were represented by substitution of a 3-mm
trocar with 5-mm or two 3-mm trocars with 5-mm as well as
unplanned additions of extra 3-mm ports or 5-mm ports.
Overall, 58 postoperative complications were observed,
accounting for a 30.2% complication rate. Most of them were
Clavien grade 1 (n = 36; 18.7%; fever, UTI, and respiratory
infections), with only one (0.5%) grade 3 and one (0.5%)
grade 4 complication recorded.
Discussion
Herein we reported the largest contemporary series of
minilaparoscopic procedures in urology, detailing indica-
tions, outcomes, and technical nuances.
Table 1. Overall Cohort Demographic Data
Patients, n 192
Mean age, years 45.25– 17.8
Male/female, n (%) 97 (50.5)/95 (49.5)
BMI, kg/m2 24.7– 3.6
ASA score 1.69 – 0.68
Race Caucasian, n (%) 192 (100)
History of abdominal/pelvic surgery, n (%) 32 (16.7)
Side
Procedures and indications, n (%) Right Left
Pyeloplasty 107 55 (51.5) 52 (48.5)
Symptoms (pain, UTI, hematuria) 86 (81)
Presence of crossing vessel 68 (63.5)
Nephrectomy 20 0 20 (100)
RCC 8 (40)
Atrophic kidney 3 (15)
Living donor 9 (45)
Adrenalectomy 37 24 (64.8) 13 (35.2)
Adrenal adenoma 31 (83.7)
Pheocromocytoma 2 (5.5)
NSLC or colon metastasis 4 (10.8)
Radical prostatectomy 13 na
PCa GS 7 7 (53)
PCa GS 6 6 (47)
Partial nephrectomy 2 2 (100) 0
RCC 2 (100)
Renal cyst decortication 4 3 (75) 1 (25)
Simple cyst 4 (100)
Colposacropexy 2 na
Pelvic organ prolapse 2 (100)
Others 7 na
Indications, n (%)
Oncological 60 (31.2)
Nononcological disease 132 (68.8)
Type of procedure, n (%)
Reconstructive 109 (56.7)
Extirpative 66 (34.3)
Target anatomy, n (%)
Upper urinary tract 133 (69.2)
Lower urinary tract 15 (7.8)
Data are expressed as mean – (SD) or as counts and (percentage).
ASA, American Society of Anesthesiologists; BMI, body mass index; NSLC, nonsmall-cell lung cancer; UTI,
bAU8
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The idea of further reducing the minimal invasiveness of
standard laparoscopy is not new. In the early 1990s this was
proposed and experimented in different surgical specialties,15
including urology.16 However, it did not become popular
because instruments were deemed to be too flimsy, reliable
scopes were not available, and the surgical techniques
themselves were not optimized. Ultimately, at that time ML
seemed to have no significant advantages and did not prog-
ress as initially imagined.
In parallel with the recent development of potentially
‘‘scarless’’ surgical techniques, such as NOTES and LESS,
there has been a renewed interest of the surgical community
toward a rediscovery of ML. This interest has been driven by
two main reasons: the boosting of manufacturers that leads to
FIG. 1. Storz minilaparo-
scopy instruments: (A) 3.9-
mm trocars (compared with
5- and 10-mm ones); (B) 3-
mm instruments introduced
through the 3.9-mm trocar;
(C) tip of bipolar 3-mm for-
ceps; and (D) 2-mm instru-
ments (compared with the 3-
mm ones).
FIG. 2. Port configuration
for different minilaparo-
scopic
4Cc
procedures: (a) radical
prostatectomy; (b) transper-
itoneal pyeloplasty; (c)
retroperitoneoscopic pyelo-
plasty; and (d) nephrectomy.
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the availability of a new generation of purpose-built instru-
mentation,17 and the fact that ML seems to be ready for im-
mediate implementation as it is based on the same established
principles of standard laparoscopy.18
At present, many procedures have been performed and in
some cases the cosmetic benefit has also been demonstrated
with an objective assessment.7 In urology, however, small
case series and case–control studies have been reported so
far.10–12 To our knowledge, this is the first large cohort re-
porting the outcomes of contemporary ML and providing an
overview of the current applications in our surgical specialty.
When looking at the overall population of our study, pa-
tients were relatively young, nonobese, and at low estimated
surgical risk. Obese patients do not represent an optimal in-
dication for ML as smaller diameter instrument shafts bend
more easily; on the other side, patients with multiple adhe-
sions from previous surgery are less suitable too.
A large spectrum of the common urologic procedures for
both upper and lower urinary tract diseases have been per-
formed and shown to be feasible duplicating the principles of
standard laparoscopy. Not surprisingly, reconstructive pro-
cedures, which do not require an additional incision to extract
a surgical specimen, thus maximizing the benefits of the
minilaparoscopic approach, were the most common.
Pyeloplasty represented the most common indication and
was performed by using both transperitoneal and retroperi-
toneal approaches. Although the present series is devoid of
data about patient satisfaction and scar assessment, Fiori
and colleagues recently evaluated cosmetic outcomes in pa-
tients undergoingminilaparoscopic and standard pyeloplasty,
by administering 3 months postoperatively a standardized
questionnaire.10 The authors found that patients who under-
went the minilaparoscopic approach were significantly more
satisfied with their cosmetic results than those who received
standard laparoscopic pyeloplasty. Besides the comparison
between ML and standard laparoscopy, it also remains to be
determined the comparison between ML and LESS. In a re-
cent randomized trial on cholecystectomy, Lee and col-
leagues found LESS to be superior to ML in terms of
cosmetic outcome, but not about postoperative pain and an-
algesic consumption.9
In a recent Cochrane meta-analysis of 13 trials comparing
miniport versus standard port laparoscopic cholecystec-
tomy, Gurusamy and colleaguesAU6c observed that patients, in
whom elective miniport laparoscopic cholecystectomy was
completed successfully, had lower pain.19 These findings
corroborate our finding of a very low VAS recorded at
discharge.
Extirpative surgeries were also performed in our series.
However, for radical prostatectomy, radical nephrectomy,
and adrenalectomy, a liberal use of standard (larger) trocars
and instruments is more likely. This can be explained by the
need of overcoming the current shortcoming of minilaparo-
scopic instrumentation and minimizing the surgical risk.
Despite technological improvements obtained with the latest
generation of instruments, some drawbacks are still present.19
The quality of vision provided by the 3-mm scope is inferior in
terms of image resolution, clarity, and light transmitting ca-
pacity, in comparison to a 10-mm laparoscope. Moreover, in
case of bleeding, the illumination-induced light absorption
causes a substantial decrease in image quality. Clip applicators
are unavailable, and this is a clear limitation, in particular,
when an extirpative procedure is planned. The use of bipolar
can partially compensate for this shortcoming. The suction
irrigation cannula, due to its small diameter, has poor flow
characteristics and, in some cases, fails to maintain a bloodless
field. The evacuation of smoke can also be compromised
by the small caliber ports, especially when an instrument is
inserted.
Nomenclature for ML, as well as other scarless techniques,
has been recently summarized by Georgiou and colleagues.20
According to this nomenclature, minilaparoscopy implies the
use of 3- to 5-mm rigid instruments and telescopes, whereas
hybrid minilaparoscopy implies the use of larger ports
(10mm).
Similar to what has been done for standard laparoscopy21
and for LESS,22 ML as well must be scrutinized for the risk
of perioperative adverse events. Adopting two standard-
ized reporting systems, the Satava and the Clavien Dindo,
our data suggested that ML is overall a safe technique,
despite this analysis, including the early experience of
participating centers. Intraoperative adverse events only
included the replacement of 3-mm trocars by 5-mm trocars
or the addition of extra ports (Satava grade 1), whereas no
conversion to open surgery was needed. The overall rate of
those events was 8.3%. Postoperative adverse events were
recorded in 30.2% of cases, most of them being low Cla-
vien grade (1 and 2).
When considering main perioperative outcomes, it can be
grossly estimated that some of the most commonly performed
procedures in the present series (e.g., pyeloplasty, nephrec-
tomy, adrenalectomy, and radical prostatectomy) compare
Table 2. Surgical Outcomes for Most Frequently Performed Mini Laparoscopic Proceduresa
Case, n ORT, min EBL, mL LOS, days VAS
Pyeloplasty 107 151.27– 52 55.42 – 47.8 5.52 – 2.49 0.59 – 0.79
Nephrectomyb 20 122.11– 41.7 52.50 – 43.27 4.60 – 2.11 1.10 – 0.57
Adrenalectomyc 37 102.78– 32.73 81.89 – 38.7 4.75 – 0.81 0.86 – 0.76
Radical prostatectomy 13 114.23– 21.20 150.00– 32.3 3.69 – 1.11 1.00 – 0.21
Values expressed as mean– SD.
aPartial nephrectomy (n = 2), renal cyst decortication (n = 4), colposacropexy (n = 2), and others (n= 7) were also performed, but not
analyzed for low number of cases.
bIncluding living donor (n = 9).
cIncluding partial (n = 8).
EBL, estimated blood loss; LOS, length of stay; ORT, operative room time; PCa GS,
bAU8
; VAS, visual analog score at discharge bAU5.
CONTEMPORARY UROLOGIC MINILAPAROSCOPY 5
END-2014-0134-ver9-Porpiglia_1P.3d 05/09/14 3:37pm Page 5
favorably with the reported series of their laparoscopic
counterparts.23–26
Some important limitations of the present study need to be
mentioned. First, it is a retrospective analysis of prospec-
tively collected data, so that the assessment has been limited
to variables that were available with sufficient quality only. A
control group was not considered and the follow-up is short.
Moreover, the surgical procedures were performed by sur-
gical teams with previous extensive laparoscopic back-
ground, so that transferring these findings in a different
setting should be done cautiously.
Conclusions
This study provides an overview of the recent evolution of
urologic ML in multiple European laparoscopic expertise
centers. A broad range of common procedures can be safely
and effectively performed with this newly rediscovered
technique, given the current availability of purpose-built in-
strumentation. By duplicating the principles of standard
laparoscopy, but potentially offering less surgical scar and
trauma, ML can be regarded as a viable option when looking
for a virtually scarless surgery.
Disclosure Statement
No competing financial interests exist.
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Abbreviations Used
ASA¼American Society of Anesthesiologists
BMI¼ body mass index
EBL¼ estimated blood loss
LESS¼ laparoendoscopic single-site surgery
LOS¼ length of stay
ML¼minilaparoscopy
NOTES¼ natural orifice translumenal endoscopic
surgery
NSLC¼ nonsmall-cell lung cancer
ORT¼ operative room time
PCa GS¼ bAU8
SD¼ standard deviation
UTI¼ bAU8
VAS¼ bAU5
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